Immuno-oncology therapy in metastatic bladder cancer: A systematic review and network meta-analysis
Francesco Chierigo1,2, Mike Wenzel2,3, Christoph Würnschimmel2,4, Rocco Simone Flammia2,5, Benedikt Horlemann2, Zhe Tian2, Fred Saad2, Felix K.H. Chun3, Derya Tilki4,6, Shahrokh F. Shariat7,8,9,10,11,12, Michele Gallucci5, Marco Borghesi1, Nazareno Suardi1, Carlo Terrone1, Pierre I. Karakiewicz2
1Department of Surgical and Diagnostic Integrated Sciences (DISC), University of Genova, Genova, Italy
2Cancer Prognostics and Health Outcomes Unit, Division of Urology, University of Montréal Health Center, Montréal, Québec, Canada
3Department of Urology, University Hospital Frankfurt, Frankfurt Am Main, Germany
4Martini-Klinik Prostate Cancer Center, University Hospital Hamburg-Eppendorf, Hamburg, Germany
5Department of Maternal-Child and Urological Sciences, Sapienza Rome University, Policlinico Umberto I Hospital, Rome, Italy
6Department of Urology, University Hospital Hamburg-Eppendorf, Hamburg, Germany
7Department of Urology, Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria
8Departments of Urology, Weill Cornell Medical College, New York, NY, USA
9Department of Urology, University of Texas Southwestern, Dallas, TX, USA
10Department of Urology, Second Faculty of Medicine, Charles University, Prague, Czech Republic
11Institute for Urology and Reproductive Health, I.M. Sechenov First Moscow State Medical University, Moscow, Russia
12Division of Urology, Department of Special Surgery, Jordan University Hospital, The University of Jordan, Amman, Jordan
Tài liệu tham khảo
Thông tin
Thông tin xuất bản
Critical Reviews in Oncology/Hematology
Tập 169
103534
Thông tin tác giả